Portrait of José Antonio Esquivel Gaytan

José Antonio Esquivel Gaytan

MD, MSc, PhD Candidate

Applied AI Workflow Designer (Healthcare & Ethics) Physician-Scientist Developer of QGuard-Med

Personal Information

Nationality
Dutch
Current Position
PhD Candidate (UMCG) · Applied AI Workflow Designer
Affiliation
Experimental Cardiology, University Medical Center Groningen

Professional Profile

Physician-scientist and PhD candidate in Experimental Cardiology (UMCG) integrating clinical insight with translational research in biomarkers, high-throughput screening, and nanoparticle concepts. I design responsible, workable AI workflows for healthcare—prompt engineering, model/tool selection, and LLM-assisted prototyping—while keeping ethics, explainability, and MDR awareness at the center.

Relevant Experience

Nov 2018 – Feb 2025

Doctoral Researcher (PhD Candidate)

University Medical Center Groningen, Netherlands

  • OPLAH & Oxidative Stress: Biomarker workflows to explore cardio-renal mechanisms and heart failure.
  • Assay & Screening: High-throughput strategy; robustness metrics (Z’, S/B); nanoparticle concepts.
  • AI-aided Comms: Data visualization and LLM-assisted documentation for scientific outputs.
  • Teaching/Collab: Contribution to seminars; cross-functional work with clinicians/data scientists.

Jun 2025 – Aug 2025

Clinical Research Investigator & AI Project Manager (Short-term)

PECTUS Respiratory Health (PANGAEA) · Girona/Barcelona, Spain

  • 3-month appointment across three healthcare-AI projects; clinical–development bridge.
  • LLM-assisted prototyping (prompt libraries, model selection: ChatGPT/Claude/Gemini; Mistral/DeepSeek via API).
  • Proposed guardrails for responsible AI (bias, explainability, privacy-by-design, MDR awareness).

2024 – 2025

Co-developer — QGuard-Med (v2.4)

Groningen / Barcelona

  • AI-driven patient prioritization using time, trend, and severity with continuous biomarker tracking.
  • Prototypes with FastAPI (backend) and Next.js (frontend), orchestrated with LLMs.
  • Finalist — Break The Gap 2025 (AI for Health & Sport Summit).

Mar 2018 – Oct 2018

Clinical Supervisor & Lecturer

Universidad del Valle de México, Mexico

  • Guided medical students in clinical rotations and delivered educational sessions.
  • Ensured high training standards in clinical and academic settings.

Nov 2017 – May 2018

Medical Researcher

Science iN, Mexico City, Mexico

  • Maintained data integrity and standardized documentation across sites.
  • Authored technical/regulatory reports with clinical teams.

Jan 2015 – Dec 2015

Community General Practitioner (Clinical Research Intern)

IMEMIC, Mexico City, Mexico

  • Supported clinical trial operations and documentation.
  • Optimized laboratory workflows and sample tracking.
  • Delivered primary consultations and education initiatives.

Jan 2014 – Dec 2014

Clinical Intern (Chief)

ISSSTE MX, Querétaro, Mexico

  • Rotations in Family Medicine, Pediatrics, and Surgery.
  • Mentored interns and improved clinical workflows.

Skills

Project & Communication

Project Management
Team Leadership
Clinical–Tech Translation
Scientific Writing
Protocol Development
Regulatory Awareness (MDR)

Translational & Clinical

Translational Medicine
Biomarker Analysis
Assay/HTS Literacy

Wet Lab & Molecular

Molecular Biology
Protein Purification
Cell Culture
Western Blot
qRT-PCR
LC-MS

AI & Data

Prompt Engineering
Model/Tool Selection
LLM-assisted Prototyping

Programming & Tools

Python (FastAPI)
JS/TS (Next.js/React)
Docker · Git
pandas/numpy (basic analytics)

Education

PhD in Biomedical/Medical Sciences

University of Groningen (UMCG)

Nov 2018 – Feb 2025

MSc in Nanotechnology & Regenerative Medicine (Distinction)

University College London (UCL)

Sep 2016 – Nov 2017

  • Honors: Awarded with Distinction
  • Project: Photochemical Internalisation for Pancreatic Cancer Treatment
  • Key Modules: Translational Medicine, Nanotechnology, Biomaterials, Tissue Engineering

MD (Physician)

Universidad Nacional Autónoma de México (UNAM)

Aug 2009 – Nov 2016

Publications

  1. Esquivel-Gaytan, A., et al. (2024). “404-error ‘Disease not found’: Unleashing the translational potential of omics approaches beyond traditional disease classification in heart failure research.” European Journal of Heart Failure. DOI: 10.1002/ejhf.3268

    Integrates omics to challenge classical HF classification and reveal novel mechanisms.

  2. Esquivel-Gaytan, A., et al. (2023). “A high-throughput screening strategy identifies adenosine 5′-monophosphate as a novel enhancer of the cardio-protective enzyme 5-oxoprolinase (OPLAH).” European Heart Journal, 44(Suppl_2), ehad655.3130. DOI: 10.1093/eurheartj/ehad655.3130

    Discovers AMP as an OPLAH modulator with potential cardioprotection.

  3. Vermeer, M.C.S.C., Esquivel-Gaytan, J.A., et al. (2022). “A translation re-initiation variant in KLHL24 causes epidermolysis bullosa simplex and dilated cardiomyopathy via intermediate filament degradation.” British Journal of Dermatology, 187(6), 1045–1048. DOI: 10.1111/bjd.21832

    Links KLHL24 variant to skin and cardiac phenotypes via filament degradation.

Languages

Certifications

Interests

CrossFit

Artificial Intelligence

Travel

Animal Welfare

Contact

Location: Groningen, Netherlands

Email: j.esquivel.gaytan@gmail.com

LinkedIn: linkedin.com/in/jose-antonio-esquivel-gaytan89

ResearchGate: Antonio-Gaytan-2

ORCID: 0000-0001-6974-1825

Website: drjaeg.com

Get in Touch